Biophytis SA (BPTSY)
8.26
-0.01
(-0.12%)
USD |
OTCM |
May 17, 15:59
Biophytis Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2019 | 2.852M |
| March 31, 2019 | 2.600M |
| Date | Value |
|---|---|
| June 30, 2018 | 2.530M |
| March 31, 2018 | 2.478M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.852M
Minimum
Jun 2019
2.852M
Maximum
Jun 2019
2.852M
Average
2.852M
Median
Jun 2019
Research and Development Expense (Quarterly) Benchmarks
| DBV Technologies SA | 21.40M |
| Cellectis SA | 25.53M |
| Genfit SA | -- |
| Edap TMS SA | 2.370M |
| Adaptimmune Therapeutics PLC | 35.21M |